PulmoDiseasics Journal is the official publication of the National Center for Respiratory and Education Institute (NCREI), Indonesia, focusing on advancing research in the field of pulmonary and respiratory health. As an international open-access peer-reviewed journal, it is dedicated to disseminating the latest scientific developments in the understanding and treatment of respiratory diseases. With the International Standard Serial Number (ISSN xxxx), PulmoDiseasics has positioned itself as a leading forum for cutting-edge empirical research and comprehensive reviews in the field of pulmonology.

The journal aims to address critical challenges in the management of respiratory illnesses, with a particular emphasis on emerging issues that complicate the stabilization of patients. Many international trusts and societies are involved in advancing global respiratory research, and this journal serves as a key platform for their efforts. By collaborating with renowned researchers worldwide, PulmoDiseasics contributes to reducing suffering and improving patient care globally.

As an open-access publication, PulmoDiseasics ensures that all its content is freely available to readers, increasing the accessibility of vital research. This wide accessibility is essential for advancing the global body of knowledge in pulmonary medicine. The more articles are accessed and cited, the higher the journal's impact factor, which reflects its contribution to the field.

PulmoDiseasics covers a broad range of topics, including but not limited to:

• Asthma, Bronchial Diseases, and Bronchioles

• Chronic Obstructive Pulmonary Disease (COPD), Cystic Fibrosis, Pulmonary Fibrosis

• Idiopathic Pulmonary Fibrosis, Interstitial Lung Diseases, and Pulmonary Edema

• Pulmonary Embolism, Pulmonary Hypertension, and Pulmonary Tuberculosis

• Lung Cancer, Respiratory Infections, and Respiratory System Diseases

• Pediatric Pulmonology, Neonatal Pulmonology, and Respiratory Physiology

• Sleep-Related Respiratory Issues, Throat Carcinoma, and much more.

The journal also supports cutting-edge research in pulmonary pharmacology, therapies, and critical care, contributing significantly to the advancement of treatment strategies and clinical practices in pulmonology.

With the support of NCREI, PulmoDiseasics plays a crucial role in promoting respiratory health and improving patient care worldwide. By publishing high-quality, impactful research, it seeks to enhance global collaboration and foster innovation in the field of pulmonary diseases. NCREI’s commitment to funding the publication of high-quality articles ensures that meaningful contributions reach the scientific community, furthering the goals of excellence in respiratory medicine and education.